Related Experiment Video

Updated: May 17, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

[Cervical cancer screening and the place of the HPV test in 2012]

F Xavier Bosch1, Christine Bergeron

  • 1Institut catala d'oncologia, Avenue Gran Via 199-201, L'Hospitalet, 08908 Barcelone, Espagne. x.bosch@iconcologia.net

Annales De Pathologie
|November 7, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Experiment Videos

Last Updated: May 17, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

Articles linked to this work by shared authors, journal, and citation graph.

Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical Carcinoma.

Cancers·2026

Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions.

EBioMedicine·2025

Accelerating HPV-related cancer elimination - a meeting report.

BMC proceedings·2025

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia (dVIN): an international reproducibility study.

Histopathology·2025

Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.

Human vaccines & immunotherapeutics·2025

Should men whose female partners have cervical high grade intraepithelial lesion (HSIL) be screened?

European journal of obstetrics, gynecology, and reproductive biology·2025

[New developments in grading of astrocytomas, IDH-mutant: Study of the impact of update 12 of cIMPACT-NOW].

Annales de pathologie·2026

[Exogenous ochronosis: An underdiagnosed cause of acquired facial hyperpigmentation].

Annales de pathologie·2026

[Diagnostic approach to non-cutaneous T-cell lymphomas in 2025: What pitfalls and how should they be classified?]

Annales de pathologie·2026

[Primary splenic angiosarcoma: A rare vascular lesion at the diagnostic boundaries].

Annales de pathologie·2026

[Digital pathology yes, but… eco-friendly!]

Annales de pathologie·2026

[Case 6: Pulmonary histoplasmosis presenting as a pseudo-tumoral lesion].

Annales de pathologie·2026

Performance of an Artificial Intelligence Program for Assessing the Depth of Early Gastric Cancer Using Endoscopic Images.

Endoscopy international open·2026

Actionable diagnostic delay in primary malignant bone tumors: a trigger-to-action framework for first-contact clinicians.

Frontiers in oncology·2026

Correction to: "Infertility as a possible diagnostic feature of Carney complex".

JCEM case reports·2026

Cancer metabolism rewiring and chromatin methylation: a vulnerable epi-metabolic link.

Frontiers in epigenetics and epigenomics·2026

Epi-liquidomics: redefining cancer diagnostics through epigenetic profiling.

Frontiers in epigenetics and epigenomics·2026

Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications.

Frontiers in epigenetics and epigenomics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us